401(k) · DOL Form 5500 · 2022

Sumitovant Biopharma, Inc. 401(k) Plan

Data updated 2026-08-25

$43M
Total assets Below avg plan size
190
Participants Below avg headcount
87th
Percentile by assets National rank
$224,249
Avg per participant Above avg balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Sumitovant Biopharma, Inc. 401(k) Plan · Sponsored by Sumitovant Biopharma, Inc. · New York · Manufacturing

$43M in assets, 190 participants

Sumitovant Biopharma, Inc.'s Sumitovant Biopharma, Inc. 401(k) Plan reported $43M in total assets and 190 participants in its 2022 DOL Form 5500 filing, ranking in the 87th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #16,580 in Manufacturing (20,602 peers)

Coverage in New York

Sumitovant Biopharma, Inc. 401(k) Plan covers 190 participants in New York, about 24% of the average New York filer (state average ~798 per filing). Assets: $43M.

#16,580
in Manufacturing (20,602 peers)
+225.4%
assets growth YoY
0.4×
vs typical plan assets (national mean)

Sumitovant Biopharma, Inc. 401(k) Plan's outsized position by total assets

Sumitovant Biopharma, Inc. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2022 · DOL Form 5500

$42,607,365 Top 13% higher than 87% of 139,123 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2022

Sumitovant Biopharma, Inc. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2022 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Sumitovant Biopharma, Inc. 401(k) Plan sits mid-pack in the medium band (190 participants).

Form 5500 schedule snapshot

Filing strip 843508458 · Sumitovant Biopharma, Inc. PY 2022 · 401(k)

Sumitovant Biopharma, Inc. 401(k) Plan · $43M · 190 · 87th

  • PART $43M
  • PART 190
  • PART 87th
  • PART 401(k)
  • PART near Continental Battery 401(k) Plan
  • PART ind #16580

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Manufacturing retirement plans → · Plans in New York →

Sumitovant Biopharma, Inc. 401(k) Plan in the asset neighbourhood

Sumitovant Biopharma, Inc. 401(k) PlanSumitovant Biopharma, Inc. 4…$43MContinental Battery 401(k) PlanContinental Battery 401(k) P…$43MMobile Communications America, Inc. 401(k) PlanMobile Communications Americ…$43MWeiss Asset Management LP 401(k) Profit Sharing PlanWeiss Asset Management LP 40…$43MFidelity Companies Employee Retirement PlanFidelity Companies Employee …$43M
End-of-year total assets ($M) among Sumitovant Biopharma, Inc. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2022.

New York filing particulars

Total Assets (Beginning of Year)$13M
Net Assets (End of Year)$43M
Net Income$10M
Employer EIN843508458
Plan Effective Date2021-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Sumitovant Biopharma, Inc.)

Sponsor-wide plan assets over time

All Sumitovant Biopharma, Inc. plans reported in each filing year

Latest sponsor-wide plan assets
N/A
2023 filing year
$0M$20M$40M$60M 20222023 $42.6M $0M ▼ -100.0%
Year Plans Participants Total Assets
2022 1 190 $43M
2023 1 545 N/A

Nearby 401(k) Plans in New York

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Sumitovant Biopharma, Inc. 401(k) Plan vs. nearby 401(k) plans in New York, assets vs. participants Scatter plot of 6 data points. -50000050000100000150000 -200204060 Total assets ($B) Participants Sumitovant Biopharma, Inc. 401(k) Plan, Total assets ($B): 0.042607365 · Participants: 190Sumitovant Biopharma, Inc. 401(k) PlanIBM 401 (K) Plus Plan, Total assets ($B): 53.363875208 · Participants: 56376IBM 401 (K) Plus PlanMorgan Stanley 401(k) Plan, Total assets ($B): 16.415517176 · Participants: 42924Morgan Stanley 401(k) PlanThe Pepsico Savings Plan, Total assets ($B): 12.067222 · Participants: 129846The Pepsico Savings PlanDeloitte 401(k) Plan, Total assets ($B): 10.966899716 · Participants: 74687Deloitte 401(k) PlanThe Goldman Sachs 401(k) Plan, Total assets ($B): 9.681988279 · Participants: 22650The Goldman Sachs 401(k) Plan
Sumitovant Biopharma, Inc. 401(k) Plan vs. nearby 401(k) plans in New York, assets vs. participants

Sumitovant Biopharma, Inc. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside New York, the nearest 401(k) by assets is Continental Battery 401(k) Plan in TX ($43M); by covered participants it is Pubco Corporation and Subsidiaries 401(k) Plan in OH (190 participants). Same-state nearby plans are listed separately above.

Similar participant headcount

Nearest other-state filings by covered participants (190 participants); asset peers above are excluded.

DOL Form 5500 plan year 2022. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Sumitovant Biopharma, Inc. 401(k) Plan assets move in 2022?
Sumitovant Biopharma, Inc. 401(k) Plan surged - up 225.4% during 2022, from $13M to $43M. Reported net income was $10M.
Where does Sumitovant Biopharma, Inc. 401(k) Plan rank by assets among Form 5500 filers?
Sumitovant Biopharma, Inc. 401(k) Plan ranks in the 87th percentile by end-of-year assets among 139,126 plans that reported assets for plan year 2022 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Sumitovant Biopharma, Inc. 401(k) Plan?
Among 401(k) plans in other states, the closest by assets is Continental Battery 401(k) Plan in TX ($43M, 748 participants).
Which 401(k) plans cover a similar participant headcount to Sumitovant Biopharma, Inc. 401(k) Plan?
Among 401(k) plans in other states, the closest by covered participants is Pubco Corporation and Subsidiaries 401(k) Plan in OH (190 participants, $18M in assets).